We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+5.47%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$299M
AUM Growth
-$9.51M
Cap. Flow
-$30.5M
Cap. Flow %
-10.19%
Top 10 Hldgs %
42.64%
Holding
104
New
18
Increased
30
Reduced
39
Closed
16

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$11.4M
2
AGN
Allergan plc
AGN
+$10.5M
3
WMGI
Wright Medical Group Inc
WMGI
+$8.41M
4
SHPG
Shire pic
SHPG
+$6.98M
5
MCK icon
McKesson
MCK
+$4.79M

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$8.16M
2
EVHC
Envision Healthcare Holdings Inc
EVHC
+$7.43M
3
ZBH icon
Zimmer Biomet
ZBH
+$7.17M
4
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$7.08M
5
MDT icon
Medtronic
MDT
+$5.39M

Sector Composition

Rank Sector Weight
1 Healthcare 88.92%
2 Financials 3.84%
3 Industrials 1.57%
4 Energy 1.04%
5 Technology 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COR icon
26
Cencora
COR
$60.6B
$3.85M 1.29%
+48,600
New +$3.9M
ZBH icon
27
Zimmer Biomet
ZBH
$18.2B
$3.76M 1.26%
32,141
-63,345
-66% -$7.17M
CRL icon
28
Charles River Laboratories
CRL
$11.2B
$3.31M 1.1%
40,088
+29,200
+268% +$2.41M
ELV icon
29
Elevance Health
ELV
$81.5B
$3.3M 1.1%
25,154
-18,470
-42% -$2.53M
LHCG
30
DELISTED
LHC Group LLC
LHCG
$3.13M 1.04%
+72,200
New +$2.94M
NVRO
31
DELISTED
NEVRO CORP.
NVRO
$3.06M 1.02%
41,484
-7,268
-15% -$493K
JNJ icon
32
Johnson & Johnson
JNJ
$618B
$2.97M 0.99%
+24,500
New +$2.78M
NSTG
33
DELISTED
NanoString Technologies, Inc.
NSTG
$2.61M 0.87%
207,468
+89,900
+76% +$1.3M
VWR
34
DELISTED
VWR Corporation
VWR
$2.37M 0.79%
82,089
-73,300
-47% -$2.06M
GILD icon
35
Gilead Sciences
GILD
$162B
$2.32M 0.78%
27,810
-40,000
-59% -$3.55M
STE icon
36
Steris
STE
$22.3B
$2.32M 0.77%
+33,700
New +$2.36M
LAB icon
37
Standard BioTools
LAB
$340M
$2.32M 0.77%
256,490
-286,800
-53% -$2.7M
SRCL
38
DELISTED
Stericycle Inc
SRCL
$2.31M 0.77%
+22,200
New +$2.38M
CELG
39
DELISTED
Celgene Corp
CELG
$2.26M 0.75%
22,880
+8,600
+60% +$890K
ESRX
40
DELISTED
Express Scripts Holding Company
ESRX
$2.1M 0.7%
27,727
-24,400
-47% -$1.79M
BKD icon
41
Brookdale Senior Living
BKD
$3.49B
$1.96M 0.66%
127,120
-56,600
-31% -$987K
NTUS
42
DELISTED
Natus Medical Inc
NTUS
$1.83M 0.61%
+48,400
New +$1.62M
HRC
43
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.8M 0.6%
35,600
-161,824
-82% -$8.16M
TNDM icon
44
Tandem Diabetes Care
TNDM
$1.34B
$1.74M 0.58%
23,067
+4,510
+24% +$363K
AMAG
45
DELISTED
AMAG Pharmaceuticals
AMAG
$1.73M 0.58%
72,380
-192,800
-73% -$4.42M
BBH icon
46
VanEck Biotech ETF
BBH
$400M
$1.67M 0.56%
+16,300
New +$1.74M
VTRS icon
47
Viatris
VTRS
$20.4B
$1.62M 0.54%
37,524
-23,700
-39% -$1.05M
MD icon
48
Pediatrix Medical
MD
$2.18B
$1.23M 0.41%
+17,000
New +$1.17M
ALR
49
DELISTED
AlerisLife Inc
ALR
$1.15M 0.38%
49,209
-18,020
-27% -$389K
EVHC
50
DELISTED
Envision Healthcare Holdings Inc
EVHC
$1.15M 0.38%
15,080
-104,626
-87% -$7.43M
1
2
3 4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Endurant Capital Management held 104 positions worth $299M, down 3.1% from $309M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Endurant Capital Management withdrew a net $30.5M in Q2 2016, closing 16 positions and reducing 39 holdings. Its most notable exit was BAXALTA INC COM STK (DE), an estimated $7.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 84% a quarter earlier, followed by Financials and Industrials.

Against the trend, Endurant Capital Management opened a new position in Cencora worth $3.85M.

  • Endurant Capital Management's largest Q2 2016 buy was Cencora: 48,600 shares worth $3.85M.
  • Endurant Capital Management added most to Abbott in Q2 2016, an estimated $11.4M increase.
  • Endurant Capital Management's biggest Q2 2016 reduction was HILL-ROM HOLDINGS, INC., cutting an estimated $8.16M.
  • Endurant Capital Management fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $7.08M.
  • Endurant Capital Management's ten largest holdings make up 43% of its $299M portfolio in Q2 2016.
  • Endurant Capital Management opened 18 new positions and closed 16 in Q2 2016.
  • Endurant Capital Management's portfolio value fell 3.1% quarter-over-quarter to $299M.

Based on Endurant Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.